Huadong Medicine Co. Ltd. held its Annual General Meeting of 2023 on 08 May 2024, during which the shareholders approved cash dividend/10 shares (tax included): CNY 5.80000000 for the year 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.37 CNY | -1.78% | -0.82% | -24.34% |
Jun. 06 | Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic | RE |
Jun. 06 | Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.34% | 7.58B | |
+26.77% | 76.29B | |
-2.27% | 23.99B | |
+10.27% | 9.01B | |
+12.25% | 8.67B | |
+12.70% | 5.18B | |
+2.89% | 4.16B | |
-4.96% | 3.98B | |
-1.36% | 3.63B | |
+20.13% | 3.58B |
- Stock Market
- Equities
- 000963 Stock
- News Huadong Medicine Co., Ltd
- Huadong Medicine Co., Ltd Approves Cash Dividend for the Year 2023